BTL Files Patent Infringement Lawsuit Against Allergan and Zimmer Related to Emsculpt

January 2, 2020

BTL Aesthetics’ U.S. affiliate has filed a lawsuit against Allergan plc, Ireland, and its affiliates, and Zimmer MedizinSysteme GmbH, Germany, and its affiliate, in the U.S. Federal District Court for the District of Delaware.
The lawsuit asserts that the CoolTone device, manufactured by Zimmer for Allergan, infringes on BTL’s U.S. patents. The lawsuit further asserts that Allergan’s CoolSculpting, when used before, or after the CoolTone therapy, infringes on BTL’s U.S. patent for the therapeutic application of the two technologies.Read more at Modern Aesthetics >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Hims & Hers Plans Launch of Peptide Treatments Following Federal Policy Shift
    • FDA Requires New Safety Warning on GLP-1 Medications for Rare Eye Condition
    • Stella Advisory Becomes Silver Vendor Affiliate with the American Med Spa Association
    • Allergan Aesthetics Reports Aesthetic Treatment Satisfaction in Patients Using GLP-1s
    • SkinSpirit Named to Fortune’s 2026 Best Workplaces in Health Care List